T. Rowe Price Investment Management, Inc. 13D and 13G filings for Applied Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-07 10:37 am Purchase |
2025-04-30 | 13G | Applied Therapeutics, Inc. APLT |
T. Rowe Price Investment Management, Inc. | 15,612,586 11.000% |
5,231,996 (+50.40%) |
Filing |
| 2025-05-07 10:19 am Purchase |
2025-03-31 | 13G | Applied Therapeutics, Inc. APLT |
T. Rowe Price Investment Management, Inc. | 10,380,590 8.900% |
10,380,590 (New Position) |
Filing |